Number of the records: 1
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
Title Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial Author info Mego M. ... [et al.] Co-authors Mego Michal
Rejleková Katarína
Světlovská Daniela
Miškovská Věra
Kalavská Katarína
Obertová Jana
Palacka Patrik
Rečková Mária
Syčová-Milá Zuzana
Pinďák Daniel
Chovanec Michal
Mardiak Jozef
Corporation Redakcia Onkológia
Note European Urology Open Science, vol. 33, November (2021), s. 19-27 Sign. C 3069 Source Onkológia. - ISSN 1336-8176. - Bratislava : SOLEN , 2021 . - Roč. 16, č. 5 (2021), s. 391 MeSH Subject nádory z germinatívnych a embryonálnych buniek : farmakoterapia
paklitaxel
ifosfamid
cisplatina
výsledok liečby
skúšanie klinické, fáza II, ako téma
Form, Genre abstrakt v angličtine
Language English Country Slovak Republic Document kind Rozpis článkov z periodík Database ARTICLES 
article
Number of the records: 1